NEUROBO PHARMACEUTICALS INC (NRBO) Stock Balance Sheet
NASDAQ:NRBO - Nasdaq - US64132R4048 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 21.67M | 22.43M | 33.36M | 16.39M | 10.09M | |||
| Other Current Assets | 266.00K | 77.00K | 170.00K | 200.00K | 600.00K | |||
| Total Current Assets | 21.93M | 22.51M | 33.53M | 16.58M | 10.68M | |||
| Non-Current Assets | ||||||||
| PPE Net | 190.00K | 248.00K | 0.00 | 220.00K | 290.00K | |||
| Other Non-Current Assets | 21.00K | 21.00K | N/A | N/A | N/A | |||
| Total Non-Current Assets | 211.00K | 269.00K | 0.00 | 220.00K | 290.00K | |||
| TOTAL ASSETS | 22.15M | 22.78M | 33.53M | 16.80M | 10.97M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 4.08M | 4.48M | 280.00K | 1.33M | 1.12M | |||
| Accounts Payable | 1.02M | 821.00K | 710.00K | 830.00K | 2.58M | |||
| Other Current Liabilities | 4.01M | 658.00K | 10.80M | N/A | N/A | |||
| Total Current Liabilities | 9.11M | 5.96M | 11.78M | 2.16M | 3.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 79.00K | 136.00K | 0.00 | 50.00K | 70.00K | |||
| Total Non-Current Liabilities | 79.00K | 136.00K | 0.00 | 40.00K | 70.00K | |||
| TOTAL LIABILITIES | 9.19M | 6.10M | 11.78M | 2.20M | 3.77M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -130.68M | -108.27M | -95.80M | -81.83M | -66.54M | |||
| Additional Paid In Capital | 143.63M | 124.94M | 117.52M | 96.39M | 73.71M | |||
| Common Shares | 9.00K | 5.00K | 30.00K | 30.00K | 20.00K | |||
| Other Shareholders' Equity | N/A | N/A | 0.00 | 0.00 | 10.00K | |||
| Shares Outstanding | 8.61M | 4.91M | 25.44M | 890.00K | 660.00K | |||
| Tangible Book Value per Share | 1.50 | 3.40 | 0.85 | 16.40 | 10.91 | |||
| Total Shareholders' Equity | 12.95M | 16.68M | 21.75M | 14.60M | 7.20M | |||
| TOTAL LIABILITIES AND EQUITY | 22.15M | 22.78M | 33.53M | 16.80M | 10.97M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 2.41 | 3.78 | 2.85 | 7.68 | 2.89 | |||
| Return On Assets (ROA) | -125.23% | -54.74% | -41.66% | -90.95% | -270.56% | |||
| Return On Equity (ROE) | -214.10% | -74.74% | -64.23% | -104.66% | -412.22% | |||
All data in USD , ROIC based on taxRate of 0.21